
Company valuation, historical trends, and peer comparisons.
According to NanoViricides, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 32.18M. This represents a change of 56.68% compared to the average of 20.54M of the last 4 quarters.
The mean historical Enterprise Value of NanoViricides, Inc. over the last ten years is 24.04M. The current 32.18M Enterprise Value has changed 33.85% with respect to the historical average. Over the past ten years (40 quarters), NNVC's Enterprise Value was at its highest in in the September 2016 quarter at 85.42M. The Enterprise Value was at its lowest in in the December 2022 quarter at 1.44M.
Average
24.04M
Median
20.54M
Minimum
5.22M
Maximum
70.00M
Discovering the peaks and valleys of NanoViricides, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 228.78%
Maximum Annual Enterprise Value = 70.00M
Minimum Annual Increase = -74.42%
Minimum Annual Enterprise Value = 5.22M
| Year | Enterprise Value | Change |
|---|---|---|
| 2026 | 25.07M | 27.85% |
| 2025 | 19.61M | 14.23% |
| 2024 | 17.16M | 228.78% |
| 2023 | 5.22M | -32.32% |
| 2022 | 7.71M | -74.42% |
| 2021 | 30.16M | 2.41% |
| 2020 | 29.45M | 102.63% |
| 2019 | 14.53M | -32.35% |
| 2018 | 21.48M | -69.31% |
| 2017 | 70.00M | -8.76% |
The current Enterprise Value of NanoViricides, Inc. (NNVC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
20.61M
5-year avg
14.95M
10-year avg
24.04M
NanoViricides, Inc.’s Enterprise Value is less than Verrica Pharmaceuticals Inc. (50.57M), greater than Jasper Therapeutics, Inc. (10.63M), less than SAB Biotherapeutics, Inc. (301.21M), less than Generation Bio Co. (40.14M), greater than Evaxion Biotech A/S (12.24M), greater than IGC Pharma, Inc. (21.36M), less than Q32 Bio Inc. (156.38M), less than MAIA Biotechnology, Inc. (42.79M), less than AN2 Therapeutics, Inc. (121.34M), greater than Tenax Therapeutics, Inc. (-70230714.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 50.57M | $59.95M | |
| 10.63M | $17.68M | |
| 301.21M | $304.35M | |
| 40.14M | $35.98M | |
| 12.24M | $19.14M | |
| 21.36M | $20.60M | |
| 156.38M | $257.36M | |
| 42.79M | $70.39M | |
| 121.34M | $165.66M | |
| -70230714.00 | $47.75M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NanoViricides, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NanoViricides, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is NanoViricides, Inc.'s Enterprise Value?
What is the highest Enterprise Value for NanoViricides, Inc. (NNVC)?
What is the 3-year average Enterprise Value for NanoViricides, Inc. (NNVC)?
What is the 5-year average Enterprise Value for NanoViricides, Inc. (NNVC)?
How does the current Enterprise Value for NanoViricides, Inc. (NNVC) compare to its historical average?